A recent abundance of findings surrounding a pathogenic role for CD8+ T-cells has emerged in JSLE research relating to their contribution to specific organ involvement and comorbidities such as atherosclerosis, as well as their systemic pro-inflammatory effects through functional and metabolic responses to type-I IFNs (Figure 1). The gene discussed is CD8A; the disease is atherosclerosis.